Circulating Metabolites of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir in Humans: Structural Identification, Levels in Plasma, and Antiviral Activities

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.45.8.2405-2405.2001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Activities of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor Nelfinavir Mesylate in Combination With Reverse Transcriptase and Protease Inhibitors Against Acute HIV-1 Infection in Vitro.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1997English

Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease Following Different Protease Inhibitor Treatments

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2003English

ABT-538 Is a Potent Inhibitor of Human Immunodeficiency Virus Protease and Has High Oral Bioavailability in Humans.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1995English

Decrease of Atazanavir and Lopinavir Plasma Concentrations in a Boosted Double Human Immunodeficiency Virus Protease Inhibitor Salvage Regimen

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

FR901724, a Novel Anti-Human Immunodeficiency Virus (HIV) Peptide Produced by Streptomyces, Shows Synergistic Antiviral Activities With HIV Protease Inhibitor and 2',3'-Dideoxynucleosides.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
1996English

Nucleoside Analog 1592U89 and Human Immunodeficiency Virus Protease Inhibitor 141W94 Are Synergistic in Vitro

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

In Vitro Resistance Profile of the Human Immunodeficiency Virus Type 1 Protease Inhibitor BMS-232632

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

Estimate of the Frequency of Human Immunodeficiency Virus Type 1 Protease Inhibitor Resistance Within Unselected Virus Populations in Vitro

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

TXU (Anti-Cd7)-Pokeweed Antiviral Protein as a Potent Inhibitor of Human Immunodeficiency Virus

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy